Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Marie Skłodowska-Curie Action · Running

iSTRIDE inter-Sectoral Training for Research on the pathology and prevention of Indwelling Device associated infEctions

Coordinator
Katholieke Universiteit Leuven, Belgium
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€2.9m
Total cost
—
Partners
16 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101227567

What the project is doing

In the project's own words, from its summary on CORDIS.

iSTRIDE will educate young scientists to develop innovative solutions to reduce the high incidence and mortality of Indwelling Device Associated Infections (IDAIs). IDAIs can be associated with urinary and intravenous catheters and cardiovascular devices, and result from microbial transfer and biofilm formation on the device surface. The clinical burden of IDAIs is significant and can be life threatening, while difficult to diagnose and to treat due to the high antibiotic tolerance of biofilm cells.

While there are antimicrobial device coatings available, their effectiveness is limited.iSTRIDE’s first objective is to provide a platform for young scientists to pursue a highly inter disciplinary PhD training focused on translational skills towards a career in biomedical research and medical technology development. iSTRIDE’s second objective is to address the challenges of IDAIs by developing novel antimicrobial coatings for indwelling devices and improved diagnostic tools to monitor their efficacy, by building on realistic IDAI models that represent all aspects of infection.iSTRIDE relies on a carefully selected inter-sectoral project consortium (six hospitals, one research institute, seven universities and three industrial partners) that crosses disciplinary borders (microbiology, material sciences and diagnostic technology).

The iSTRIDE training programme is structured so that each DC will work on the interface of at least two of these disciplines via the host lab and secondments. The consortium includes expertise from the clinical, engineering, polymer chemistry, microbiology, soft matter engineering and cell biology domains, and involves companies active in advanced diagnostics and the medical device industry. Partner organisations from different regions of Europe will provide clinical samples, and each DC will experience a secondment at a hospital to gain awareness of the clinical context of their work.

Topics

Who is involved

OrganisationCityCountryRole
Katholieke Universiteit LeuvenLeuvenBelgiumCoordinator
Amynas BVDuffelBelgiumAssociatedpartner
Sirris Het Collectief Centrum Van De Technologische IndustrieBruxelles / BrusselBelgiumAssociatedpartner
Universiteit GentGentBelgiumParticipant
Klinikum Der Universitaet RegensburgRegensburgGermanyParticipant
Moki Analytics GmbHBerlinGermanyParticipant
Universitaet LeipzigLeipzigGermanyParticipant
Universitaet RegensburgRegensburgGermanyAssociatedpartner
Academisch Ziekenhuis GroningenGroningenNetherlandsAssociatedpartner
Academisch Medisch Centrum (AMC)AmsterdamNetherlandsAssociatedpartner
Inbiome BVAmsterdamNetherlandsAssociatedpartner
Universidade Do PortoPortoPortugalParticipant
Universitatea De Medicina Si Farmacie Victor Babes TimisoaraTimisoaraRomaniaAssociatedpartner
Univerza V LjubljaniLjubljanaSloveniaParticipant
Univerzitetni Klinicni Center LjubljanaLjubljanaSloveniaAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI